Stockreport

Editas Stock Rises on Updated Data From SCD Study of Reni-Cel [Yahoo! Finance]

Editas Medicine, Inc.  (EDIT) 
Last editas medicine, inc. earnings: 2/26 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com
PDF disease (SCD) study of its lead candidate, renizgamglogene autogedtemcel (reni-cel; formerly known as EDIT-301). The data readout is from 28 SCD patients who have been t [Read more]